Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1970 1
1972 1
1973 1
1974 1
1975 2
1976 1
1979 1
1980 1
1982 4
1983 1
1984 1
1985 3
1986 5
1987 2
1988 2
1989 4
1990 5
1991 10
1992 9
1993 8
1994 14
1995 11
1996 14
1997 11
1998 13
1999 20
2000 19
2001 8
2002 13
2003 18
2004 23
2005 21
2006 27
2007 34
2008 31
2009 36
2010 41
2011 51
2012 52
2013 68
2014 80
2015 78
2016 104
2017 96
2018 90
2019 92
2020 94
2021 125
2022 111
2023 92
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

1,429 results

Results by year

Filters applied: . Clear all
Page 1
Does SARS-CoV-2 infect platelets?
Subramaniam S, Mohiuddin N, Jose A. Subramaniam S, et al. Front Immunol. 2024 Apr 23;15:1392000. doi: 10.3389/fimmu.2024.1392000. eCollection 2024. Front Immunol. 2024. PMID: 38715614 Free PMC article. No abstract available.
The Role of HSP90 and TRAP1 Targets on Treatment in Hepatocellular Carcinoma.
Praveen Kumar PK, Sundar H, Balakrishnan K, Subramaniam S, Ramachandran H, Kevin M, Michael Gromiha M. Praveen Kumar PK, et al. Among authors: subramaniam s. Mol Biotechnol. 2024 Apr 29. doi: 10.1007/s12033-024-01151-4. Online ahead of print. Mol Biotechnol. 2024. PMID: 38684604 Review.
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial.
Emmett L, Subramaniam S, Crumbaker M, Nguyen A, Joshua AM, Weickhardt A, Lee ST, Ng S, Francis RJ, Goh JC, Pattison DA, Tan TH, Kirkwood ID, Gedye C, Rutherford NK, Sandhu S, Kumar AR, Pook D, Ramdave S, Nadebaum DP, Voskoboynik M, Redfern AD, Macdonald W, Krieger L, Schembri G, Chua W, Lin P, Horvath L, Bastick P, Butler P, Zhang AY, Yip S, Thomas H, Langford A, Hofman MS, McJannett M, Martin AJ, Stockler MR, Davis ID; ENZA-p Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Emmett L, et al. Among authors: subramaniam s. Lancet Oncol. 2024 May;25(5):563-571. doi: 10.1016/S1470-2045(24)00135-9. Epub 2024 Apr 12. Lancet Oncol. 2024. PMID: 38621400 Clinical Trial.
Rhes, a striatal enriched protein, regulates post-translational small-ubiquitin-like-modifier (SUMO) modification of nuclear proteins and alters gene expression.
Rivera O, Sharma M, Dagar S, Shahani N, Ramĺrez-Jarquĺn UN, Crynen G, Karunadharma P, McManus F, Bonneil E, Pierre T, Subramaniam S. Rivera O, et al. Among authors: subramaniam s. Cell Mol Life Sci. 2024 Apr 8;81(1):169. doi: 10.1007/s00018-024-05181-8. Cell Mol Life Sci. 2024. PMID: 38589732 Free PMC article.
1,429 results